Chatbots and COVID-19: Taking Stock of the Lessons Learned.


Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
21 Mar 2024
Historique:
received: 23 11 2023
accepted: 20 12 2023
revised: 20 12 2023
medline: 22 3 2024
pubmed: 21 3 2024
entrez: 21 3 2024
Statut: epublish

Résumé

While digital innovation in health was already rapidly evolving, the COVID-19 pandemic has accelerated the generation of digital technology tools, such as chatbots, to help increase access to crucial health information and services to those who were cut off or had limited contact with health services. This theme issue titled "Chatbots and COVID-19" presents articles from researchers and practitioners across the globe, describing the development, implementation, and evaluation of chatbots designed to address a wide range of health concerns and services. In this editorial, we present some of the key challenges and lessons learned arising from the content of this theme issue. Most notably, we note that a stronger evidence base is needed to ensure that chatbots and other digital tools are developed to best serve the needs of population health.

Identifiants

pubmed: 38512309
pii: v26i1e54840
doi: 10.2196/54840
pmc: PMC10959167
doi:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e54840

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

©Virginia Arnold, Tina D Purnat, Robert Marten, Andrew Pattison, Hebe Gouda. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 21.03.2024.

Références

J Med Internet Res. 2023 Jun 14;25:e35573
pubmed: 35584083
J Med Internet Res. 2022 Nov 4;24(11):e38743
pubmed: 36219754
J Med Internet Res. 2022 Sep 26;24(9):e35556
pubmed: 36095295
JMIR Form Res. 2023 May 8;7:e41148
pubmed: 37074978
JMIR Hum Factors. 2023 Jun 8;10:e42740
pubmed: 36350760
J Med Internet Res. 2023 Jun 8;25:e40635
pubmed: 37146178
JMIR Form Res. 2023 Apr 6;7:e43165
pubmed: 36961920
JMIR Form Res. 2023 Jan 25;7:e39045
pubmed: 36630649
JMIR Hum Factors. 2023 Apr 3;10:e43135
pubmed: 36634267
J Med Internet Res. 2023 Mar 10;25:e39054
pubmed: 36745776
JMIR Form Res. 2023 Jan 25;7:e38500
pubmed: 36512402
J Med Internet Res. 2023 May 9;25:e44804
pubmed: 37126593
JMIR Form Res. 2023 Jan 26;7:e41913
pubmed: 36540052
J Med Internet Res. 2022 Nov 21;24(11):e40719
pubmed: 36355633
J Med Internet Res. 2023 Nov 8;25:e47219
pubmed: 37938887
JMIR Hum Factors. 2022 Oct 11;9(4):e39102
pubmed: 35930555
JMIR Diabetes. 2023 May 5;8:e40641
pubmed: 36939680
J Med Internet Res. 2022 Oct 4;24(10):e39063
pubmed: 36179132
J Med Internet Res. 2023 Jun 5;25:e43113
pubmed: 37195688
JMIR Hum Factors. 2022 Oct 5;9(4):e35882
pubmed: 36197708
J Med Internet Res. 2023 Dec 5;25:e42310
pubmed: 38051571
J Med Internet Res. 2023 Jul 26;25:e43068
pubmed: 37224277
J Med Internet Res. 2022 Oct 21;24(10):e39218
pubmed: 36179147
JMIR Hum Factors. 2023 Jan 30;10:e40533
pubmed: 36409300
J Med Internet Res. 2022 Dec 27;24(12):e35903
pubmed: 36520624
JMIR Hum Factors. 2022 Jun 9;9(2):e36831
pubmed: 35576058
JMIR Form Res. 2022 Oct 20;6(10):e37877
pubmed: 36150049

Auteurs

Virginia Arnold (V)

Department of Social Determinants of Health, Division of UHC Healthier Populations, World Health Organization, Geneva, Switzerland.

Tina D Purnat (TD)

Department of Epidemic and Pandemic Preparedness and Prevention, Emergencies Programme, World Health Organization, Geneva, Switzerland.
University of Memphis School of Public Health, Memphis, TN, United States.

Robert Marten (R)

Alliance for Health Policy and Systems Research, Science Division, World Health Organization, Geneva, Switzerland.

Andrew Pattison (A)

Department of Digital Health and Innovation, Science Division, World Health Organization, Geneva, Switzerland.

Hebe Gouda (H)

Department of Health Promotion, Division of UHC Healthier Populations, World Health Organization, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH